Publications by authors named "Ana Cebrian"

Claim this Profile
A
A primary care guide to the screening and pharmacologic management of chronic kidney disease in people living with type 2 diabetes.
Eugene E Wright, Ana Cebrian, Daniel Ngui

Prim Care Diabetes· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Primary Care Guide to the Screening and Pharmacologic Management of Chronic Kidney Disease in People Living With Type 2 Diabetes.
Eugene E Wright, Ana Cebrian, Daniel Ngui

Clin Diabetes· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular and renal outcomes according to KDIGO stages of chronic kidney disease in the Spanish population: Insights from real-world evidence.
Rafael Santamaria, Carlos Escobar, Unai Aranda, Beatriz Palacios, Margarita Capel

Nefrologia (Engl Ed)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multidisciplinary Delphi study on residual risk in patients with chronic kidney disease and type 2 diabetes mellitus.
Alberto Ortiz, Ana Cebrián, Alfonso Soto, Andrés Reyes, Jose Luis Górriz

Nefrologia (Engl Ed)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perspectives of clinicians and screening candidates on shared decision-making in prostate cancer screening with the prostate-specific antigen (PSA) test: a qualitative study (PROSHADE study).
María José Sanchis, Mercedes Guilabert, Lucy A Parker, Juan Pablo Caballero-Romeu, Elisa Chilet-Rosell

BMJ Evid Based Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Magnitude of chronic kidney disease in Spain.
Rafael Santamaria, Carlos Escobar, Unai Aranda, Beatriz Palacios, Margarita Capel

Nefrologia (Engl Ed)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Social Determinants as Mediators of the Emotional State of People With Type 2 Diabetes and/or Hypertension During the COVID-19 Pandemic in Ecuador and Spain.
María José Sanchís-Ramón, Elisa Chilet-Rosell, Andrés Peralta, Marta Puig-García, María Fernanda Rivadeneira

Health Expect· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International Nephrology Masterclass in Chronic Kidney Disease: Rationale, Summary, and Future Perspectives.
Francesco Pesce, Maria Vadalà, Edgar Almeida, Beatriz Fernandez, Denis Fouque, Ana Cebrian

Life (Basel)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suboptimal monitoring and management in patients with unrecorded stage 3 chronic kidney disease in real-world settings: Insights from REVEAL-CKD.
Navdeep Tangri, Christian S Alvarez, Matthew Arnold, Salvatore Barone, Ana Cebrián

Eur J Clin Invest· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Identification and Management of Chronic Kidney Disease: A Narrative Review of the Crucial Role of Primary Care Practitioners.
Pamela Kushner, Kamlesh Khunti, Ana Cebrián, Gary Deed

Adv Ther· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Including KDIGO cardiovascular risk stratification into SCORE scale could improve the accuracy to better stratify cardiovascular risk.
Ana Cebrian, Carlos Escobar, Unai Aranda, Beatriz Palacios, Margarita Capel

Nefrologia (Engl Ed)· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Knowledge and practices regarding prostate cancer screening in Spanish men: The importance of personal and clinical characteristics (PROSHADE study).
Lucy A Parker, Juan-Pablo Caballero-Romeu, Elisa Chilet-Rosell, Ildefonso Hernandez-Aguado, Luis Gómez-Pérez

PLoS One· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multistate model and its standalone tool to predict hospital and ICU occupancy by patients with COVID-19.
Miguel Lafuente, Francisco Javier López, Pedro Mariano Mateo, Ana Carmen Cebrián, Jesús Asín

Heliyon· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erectile dysfunction, phosphodiesterase-5 inhibitor use and risk of cardiovascular disease and mortality in people with diabetes: A systematic review and meta-analysis.
Samuel Seidu, Ana Cebrián, Setor K Kunutsor, Kamlesh Khunti

Prim Care Diabetes· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The 2021 European Society of Cardiology Cardiovascular Disease Prevention Guidelines: adding albuminuria to the SCORE scale increases the prevalence of very high/high cardiovascular risk among patients with chronic kidney disease.
Ana Cebrian, Carlos Escobar, Unai Aranda, Beatriz Palacios, Margarita Capel

Clin Kidney J· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Place and Value of Sodium-Glucose Cotransporter 2 Inhibitors in the Evolving Treatment Paradigm for Type 2 Diabetes Mellitus: A Narrative Review.
John P H Wilding, Marc Evans, Kevin Fernando, Jose Luis Gorriz, Ana Cebrian

Diabetes Ther· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-human study of the INCRAFT endograft in patients with infrarenal abdominal aortic aneurysms in the INNOVATION trial.
Dierk Scheinert, Carlo Pratesi, Roberto Chiesa, Gioachino Coppi, Jan S Brunkwall, Ana Cebrian

J Vasc Surg· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Four-year follow-up of TYPHOON (trial to assess the use of the CYPHer sirolimus-eluting coronary stent in acute myocardial infarction treated with BallOON angioplasty).
Christian Spaulding, Emmanuel Teiger, Philippe Commeau, Olivier Varenne, Ezio Bramucci, Ana Cebrian

JACC Cardiovasc Interv· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Six-month results of the NEVO Res-Elution I (NEVO RES-I) trial: a randomized, multicenter comparison of the NEVO sirolimus-eluting coronary stent with the TAXUS Liberté paclitaxel-eluting stent in de novo native coronary artery lesions.
John A Ormiston, Alexandre Abizaid, John Spertus, Jean Fajadet, Laura Mauri, Ana Cebrian

Circ Cardiovasc Interv· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost effectiveness of sirolimus-eluting stents compared with bare metal stents in acute myocardial infarction: insights from the TYPHOON trial.
Florence Canoui-Poitrine, Grégoire Jeanblanc, Corinne Alberti, Priscilla Armoogum, Ana Cebrian

Appl Health Econ Health Policy· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of stent length on restenosis in patients with acute myocardial infarction treated with primary percutaneous coronary intervention: analysis based on data from the Trial to Assess the Use of the Cypher Stent in Acute Myocardial Infarction Treated with Balloon Angioplasty (TYPHOON).
Yoseph Rozenman, Valentin Witzling, Israel Tamari, Vladimir Turkisher, Michael Kriviski, Ana Cebrian

EuroIntervention· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sirolimus-eluting versus uncoated stents in acute myocardial infarction.
Christian Spaulding, Patrick Henry, Emmanuel Teiger, Kevin Beatt, Ezio Bramucci, Ana Cebrian

N Engl J Med· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overexpression of parathyroid hormone-related protein inhibits pancreatic beta-cell death in vivo and in vitro.
Ana Cebrian, Adolfo García-Ocaña, Karen K Takane, Darinka Sipula, Andrew F Stewart

Diabetes· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis